Australia markets open in 7 hours 3 minutes

Kellogg Company (K)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
66.34+0.51 (+0.77%)
As of 11:57AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 22.18B
Enterprise value 29.06B
Trailing P/E 23.20
Forward P/E 16.03
PEG ratio (5-yr expected) 2.72
Price/sales (ttm)1.45
Price/book (mrq)5.63
Enterprise value/revenue 1.90
Enterprise value/EBITDA 15.35

Trading information

Stock price history

Beta (5Y monthly) 0.43
52-week change 33.10%
S&P500 52-week change 3-14.12%
52-week high 377.17
52-week low 363.23
50-day moving average 366.73
200-day moving average 370.92

Share statistics

Avg vol (3-month) 32.22M
Avg vol (10-day) 32.72M
Shares outstanding 5342.67M
Implied shares outstanding 6N/A
Float 8337.34M
% held by insiders 16.84%
% held by institutions 187.24%
Shares short (14 Mar 2023) 49.75M
Short ratio (14 Mar 2023) 44.57
Short % of float (14 Mar 2023) 43.48%
Short % of shares outstanding (14 Mar 2023) 42.84%
Shares short (prior month 14 Feb 2023) 410.76M

Dividends & splits

Forward annual dividend rate 42.36
Forward annual dividend yield 43.58%
Trailing annual dividend rate 32.34
Trailing annual dividend yield 33.55%
5-year average dividend yield 43.52
Payout ratio 483.87%
Dividend date 314 Mar 2023
Ex-dividend date 427 Feb 2023
Last split factor 22:1
Last split date 324 Aug 1997

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Dec 2022


Profit margin 6.27%
Operating margin (ttm)10.55%

Management effectiveness

Return on assets (ttm)5.51%
Return on equity (ttm)22.40%

Income statement

Revenue (ttm)15.32B
Revenue per share (ttm)44.83
Quarterly revenue growth (yoy)12.10%
Gross profit (ttm)4.62B
Net income avi to common (ttm)960M
Diluted EPS (ttm)2.79
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)348M
Total cash per share (mrq)1.02
Total debt (mrq)7.28B
Total debt/equity (mrq)166.45
Current ratio (mrq)0.66
Book value per share (mrq)11.53

Cash flow statement

Operating cash flow (ttm)1.65B
Levered free cash flow (ttm)852.12M